| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trans-Activators | 14 | 2021 | 799 | 1.010 |
Why?
|
| Nuclear Receptor Coactivator 1 | 11 | 2019 | 238 | 0.920 |
Why?
|
| Nuclear Receptor Coactivator 3 | 16 | 2018 | 348 | 0.850 |
Why?
|
| Odorants | 2 | 2020 | 75 | 0.830 |
Why?
|
| Soy Foods | 1 | 2020 | 9 | 0.690 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2015 | 341 | 0.680 |
Why?
|
| Histone Acetyltransferases | 10 | 2008 | 314 | 0.640 |
Why?
|
| Fish Diseases | 4 | 2019 | 10 | 0.630 |
Why?
|
| Carps | 4 | 2019 | 10 | 0.630 |
Why?
|
| Twist-Related Protein 1 | 6 | 2023 | 35 | 0.610 |
Why?
|
| Mice, Knockout | 27 | 2025 | 3742 | 0.600 |
Why?
|
| Nuclear Proteins | 9 | 2025 | 1266 | 0.590 |
Why?
|
| Mice | 56 | 2025 | 17645 | 0.520 |
Why?
|
| CRISPR-Cas Systems | 4 | 2024 | 253 | 0.500 |
Why?
|
| Mice, Transgenic | 15 | 2024 | 2397 | 0.470 |
Why?
|
| Animals | 64 | 2025 | 34235 | 0.460 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2024 | 34 | 0.420 |
Why?
|
| Prostatic Neoplasms | 7 | 2019 | 1546 | 0.410 |
Why?
|
| Cell Differentiation | 10 | 2025 | 1896 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 618 | 0.390 |
Why?
|
| Reoviridae | 4 | 2019 | 38 | 0.390 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2015 | 54 | 0.380 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 2524 | 0.370 |
Why?
|
| Breast Neoplasms | 11 | 2016 | 2509 | 0.360 |
Why?
|
| Gene Editing | 3 | 2024 | 187 | 0.360 |
Why?
|
| Reoviridae Infections | 3 | 2019 | 8 | 0.350 |
Why?
|
| Taste | 2 | 2020 | 31 | 0.350 |
Why?
|
| Transcription Factors | 13 | 2021 | 2594 | 0.350 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2015 | 28 | 0.320 |
Why?
|
| Stem Cells | 5 | 2021 | 706 | 0.310 |
Why?
|
| Phosphoproteins | 3 | 2018 | 418 | 0.300 |
Why?
|
| Liver | 4 | 2021 | 1742 | 0.280 |
Why?
|
| RANK Ligand | 2 | 2025 | 52 | 0.260 |
Why?
|
| Cell Movement | 5 | 2017 | 846 | 0.250 |
Why?
|
| Growth Hormone | 1 | 2006 | 150 | 0.250 |
Why?
|
| Repressor Proteins | 5 | 2012 | 815 | 0.240 |
Why?
|
| Coix | 1 | 2025 | 1 | 0.240 |
Why?
|
| Carrageenan | 1 | 2025 | 4 | 0.240 |
Why?
|
| Glutens | 1 | 2025 | 10 | 0.240 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 17 | 0.240 |
Why?
|
| Triticum | 1 | 2025 | 34 | 0.240 |
Why?
|
| Plant Oils | 1 | 2025 | 33 | 0.230 |
Why?
|
| Seeds | 1 | 2025 | 42 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 209 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2017 | 1892 | 0.220 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 163 | 0.220 |
Why?
|
| Sonication | 2 | 2020 | 8 | 0.220 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2015 | 246 | 0.220 |
Why?
|
| Osteoblasts | 1 | 2025 | 149 | 0.220 |
Why?
|
| DNA Helicases | 1 | 2025 | 231 | 0.210 |
Why?
|
| Hypothalamus | 3 | 2023 | 213 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 377 | 0.210 |
Why?
|
| Serine | 2 | 2016 | 174 | 0.210 |
Why?
|
| Signal Transduction | 9 | 2021 | 4534 | 0.200 |
Why?
|
| Spermatogenesis | 3 | 2015 | 170 | 0.200 |
Why?
|
| Uterus | 4 | 2012 | 569 | 0.200 |
Why?
|
| Cell Line, Tumor | 11 | 2019 | 3344 | 0.200 |
Why?
|
| Oocytes | 2 | 2024 | 297 | 0.200 |
Why?
|
| Mammary Glands, Animal | 7 | 2013 | 481 | 0.200 |
Why?
|
| Cyprinidae | 1 | 2021 | 3 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 272 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2023 | 189 | 0.190 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 12 | 0.190 |
Why?
|
| Phenylketonurias | 1 | 2021 | 13 | 0.190 |
Why?
|
| Cloning, Molecular | 2 | 2018 | 897 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2021 | 128 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 148 | 0.180 |
Why?
|
| Citrus | 1 | 2020 | 6 | 0.180 |
Why?
|
| Glycoside Hydrolases | 1 | 2020 | 17 | 0.180 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 9 | 0.180 |
Why?
|
| Neoplasms | 4 | 2023 | 2780 | 0.180 |
Why?
|
| Memory | 1 | 2024 | 361 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 139 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 620 | 0.180 |
Why?
|
| Zygosaccharomyces | 1 | 2020 | 1 | 0.170 |
Why?
|
| Enterococcaceae | 1 | 2020 | 1 | 0.170 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 79 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 185 | 0.170 |
Why?
|
| Fermentation | 1 | 2020 | 66 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2022 | 737 | 0.170 |
Why?
|
| Estradiol | 4 | 2015 | 532 | 0.170 |
Why?
|
| Female | 37 | 2024 | 66577 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1708 | 0.170 |
Why?
|
| Galectin 1 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 152 | 0.170 |
Why?
|
| Osteoclasts | 2 | 2025 | 55 | 0.160 |
Why?
|
| Apoptosis | 7 | 2018 | 1802 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 96 | 0.160 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 686 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2014 | 22 | 0.160 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 147 | 0.160 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 7 | 0.160 |
Why?
|
| Trachea | 1 | 2021 | 202 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 248 | 0.160 |
Why?
|
| Androgens | 2 | 2018 | 274 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1023 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 213 | 0.160 |
Why?
|
| Embryonic Development | 1 | 2020 | 214 | 0.150 |
Why?
|
| Submandibular Gland | 1 | 2018 | 7 | 0.150 |
Why?
|
| Serpins | 1 | 2018 | 27 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2013 | 428 | 0.150 |
Why?
|
| Integrin beta1 | 1 | 2018 | 56 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 879 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1113 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 553 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2018 | 39 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2018 | 56 | 0.150 |
Why?
|
| Epithelial Cells | 5 | 2018 | 909 | 0.150 |
Why?
|
| Nuclear Receptor Coactivators | 4 | 2015 | 72 | 0.150 |
Why?
|
| Crosses, Genetic | 4 | 2019 | 163 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 109 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 74 | 0.150 |
Why?
|
| Morphogenesis | 3 | 2018 | 212 | 0.150 |
Why?
|
| Cardiomegaly | 1 | 2018 | 135 | 0.150 |
Why?
|
| RNA, Messenger | 7 | 2012 | 2821 | 0.140 |
Why?
|
| Male | 28 | 2024 | 61317 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2018 | 91 | 0.140 |
Why?
|
| Cell Plasticity | 1 | 2017 | 32 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 149 | 0.140 |
Why?
|
| Oxygen | 1 | 2021 | 555 | 0.140 |
Why?
|
| Prealbumin | 2 | 2008 | 27 | 0.140 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 201 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 799 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 375 | 0.130 |
Why?
|
| Neurons | 3 | 2024 | 1932 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 291 | 0.130 |
Why?
|
| Obesity | 3 | 2022 | 2248 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 345 | 0.130 |
Why?
|
| Fishes | 1 | 2016 | 38 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2018 | 538 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 429 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 4406 | 0.130 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 1660 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 278 | 0.130 |
Why?
|
| Estrogens | 2 | 2012 | 504 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 49 | 0.120 |
Why?
|
| MafB Transcription Factor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 795 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 87 | 0.120 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1701 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 115 | 0.120 |
Why?
|
| Protein Binding | 5 | 2021 | 1752 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2023 | 216 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 240 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 638 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 127 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Cell Proliferation | 6 | 2021 | 2303 | 0.110 |
Why?
|
| Leptin | 2 | 2019 | 214 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 54 | 0.110 |
Why?
|
| Body Weight | 4 | 2019 | 990 | 0.110 |
Why?
|
| Bufanolides | 1 | 2014 | 17 | 0.110 |
Why?
|
| Gene Expression | 6 | 2013 | 1561 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 256 | 0.110 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2024 | 16 | 0.110 |
Why?
|
| Gene Knockout Techniques | 4 | 2018 | 124 | 0.110 |
Why?
|
| Embryo Implantation | 2 | 2012 | 234 | 0.110 |
Why?
|
| Humans | 29 | 2024 | 124705 | 0.110 |
Why?
|
| Hepatocytes | 2 | 2021 | 208 | 0.110 |
Why?
|
| Hair Follicle | 1 | 2013 | 34 | 0.110 |
Why?
|
| Health | 1 | 2013 | 37 | 0.110 |
Why?
|
| Myocardium | 1 | 2018 | 1020 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 410 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 236 | 0.100 |
Why?
|
| Serotonin | 2 | 2024 | 219 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 357 | 0.100 |
Why?
|
| Receptors, Androgen | 4 | 2019 | 414 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 207 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2019 | 564 | 0.100 |
Why?
|
| Phylogeny | 3 | 2019 | 696 | 0.090 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 9 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 664 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2011 | 36 | 0.090 |
Why?
|
| Aging | 3 | 2015 | 1183 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 95 | 0.090 |
Why?
|
| Embryo, Mammalian | 3 | 2018 | 460 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 111 | 0.090 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 12 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 2 | 2011 | 514 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 496 | 0.090 |
Why?
|
| Lactation | 1 | 2011 | 193 | 0.080 |
Why?
|
| Fertility | 1 | 2012 | 257 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 78 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 558 | 0.080 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 222 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 281 | 0.080 |
Why?
|
| Hydroxycholecalciferols | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 781 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3055 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1291 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1694 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 2048 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 131 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 702 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2021 | 789 | 0.080 |
Why?
|
| Disease Progression | 5 | 2018 | 2057 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 97 | 0.070 |
Why?
|
| Exons | 2 | 2018 | 797 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 139 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 270 | 0.070 |
Why?
|
| RNA Interference | 3 | 2015 | 500 | 0.070 |
Why?
|
| Chromatin | 2 | 2018 | 552 | 0.070 |
Why?
|
| Cell Line | 4 | 2015 | 2756 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2015 | 311 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2021 | 383 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 276 | 0.070 |
Why?
|
| Alleles | 3 | 2019 | 1615 | 0.070 |
Why?
|
| Dwarfism | 1 | 2008 | 98 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 249 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 838 | 0.070 |
Why?
|
| Heterozygote | 3 | 2019 | 671 | 0.070 |
Why?
|
| Infertility, Male | 1 | 2009 | 263 | 0.070 |
Why?
|
| Pregnancy | 5 | 2020 | 7171 | 0.070 |
Why?
|
| Histones | 1 | 2009 | 525 | 0.060 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 74 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 1024 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 487 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 444 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 208 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 10 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 539 | 0.060 |
Why?
|
| Emulsions | 1 | 2025 | 69 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 769 | 0.060 |
Why?
|
| Gels | 1 | 2025 | 69 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 62 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 57 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2025 | 137 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 100 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 88 | 0.060 |
Why?
|
| Testis | 2 | 2004 | 409 | 0.060 |
Why?
|
| Genotype | 3 | 2008 | 2558 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 1204 | 0.060 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2025 | 71 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2006 | 266 | 0.060 |
Why?
|
| Zygote | 1 | 2024 | 30 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 427 | 0.060 |
Why?
|
| Sertoli Cells | 1 | 2004 | 77 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4396 | 0.050 |
Why?
|
| Cell Count | 2 | 2021 | 254 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 100 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 106 | 0.050 |
Why?
|
| Anoctamins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2015 | 231 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 75 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2023 | 28 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2020 | 1008 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 312 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 21 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 5845 | 0.050 |
Why?
|
| Gene Targeting | 3 | 2013 | 177 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 806 | 0.050 |
Why?
|
| Homeostasis | 2 | 2019 | 700 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 90 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 275 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 215 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 96 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1631 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2002 | 40 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 59 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 136 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 300 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 10 | 0.050 |
Why?
|
| Acetylation | 1 | 2021 | 164 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 106 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 581 | 0.050 |
Why?
|
| Purkinje Cells | 1 | 2003 | 159 | 0.050 |
Why?
|
| Prolyl Hydroxylases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 108 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 817 | 0.050 |
Why?
|
| Chromosomes | 1 | 2021 | 199 | 0.050 |
Why?
|
| Flavoring Agents | 1 | 2020 | 4 | 0.050 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 22 | 0.040 |
Why?
|
| Superovulation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 184 | 0.040 |
Why?
|
| Aspergillus niger | 1 | 2020 | 20 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 25 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 54 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 765 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 75 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2020 | 161 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 58 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 503 | 0.040 |
Why?
|
| Ovary | 1 | 2003 | 380 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 87 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 812 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 1006 | 0.040 |
Why?
|
| Base Sequence | 2 | 2019 | 3101 | 0.040 |
Why?
|
| Fish Proteins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2021 | 201 | 0.040 |
Why?
|
| Poly I-C | 1 | 2019 | 23 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 760 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 450 | 0.040 |
Why?
|
| Motor Activity | 1 | 2003 | 522 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1330 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1036 | 0.040 |
Why?
|
| Keratin-14 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 1103 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 220 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 4258 | 0.040 |
Why?
|
| Aquaculture | 1 | 2018 | 6 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 1136 | 0.040 |
Why?
|
| Clathrin | 1 | 2018 | 24 | 0.040 |
Why?
|
| Hydrazones | 1 | 2018 | 19 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 123 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 824 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 255 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 28 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2018 | 55 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 508 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 35 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 281 | 0.040 |
Why?
|
| Endocytosis | 1 | 2018 | 125 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2019 | 306 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2019 | 621 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 293 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 458 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 120 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2011 | 440 | 0.040 |
Why?
|
| Interleukins | 1 | 2018 | 119 | 0.040 |
Why?
|
| Models, Biological | 1 | 2002 | 1460 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 588 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2018 | 302 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 488 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 435 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 343 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 628 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 339 | 0.030 |
Why?
|
| Fresh Water | 1 | 2016 | 18 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 370 | 0.030 |
Why?
|
| Ecosystem | 1 | 2016 | 77 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 89 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 95 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 17 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1243 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 867 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 458 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 94 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 309 | 0.030 |
Why?
|
| Antibodies | 2 | 2009 | 375 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 95 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1017 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 172 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 238 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2717 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 237 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 22 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 120 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 236 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 28 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 369 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 295 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 874 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1141 | 0.030 |
Why?
|
| Pituitary Gland | 2 | 2005 | 82 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 103 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 64 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 156 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 52 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 230 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 43 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 362 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 74 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 49 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 419 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.030 |
Why?
|
| Ovariectomy | 2 | 2004 | 183 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 883 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 53 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 327 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1498 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 499 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 556 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3728 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2807 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 80 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 701 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 259 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 37 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 104 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 67 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 898 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 16 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 547 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 336 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 621 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 305 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 41 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 344 | 0.020 |
Why?
|
| Copulation | 1 | 2009 | 10 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 835 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2009 | 23 | 0.020 |
Why?
|
| Spermatids | 1 | 2009 | 25 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 118 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 109 | 0.020 |
Why?
|
| Oligospermia | 1 | 2009 | 57 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 230 | 0.020 |
Why?
|
| Cadherins | 1 | 2010 | 171 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 17 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 313 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 222 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 113 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 717 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 293 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 262 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 174 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 375 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1143 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 471 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 332 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 462 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 63 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 57 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1326 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2005 | 112 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 15 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 1002 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 152 | 0.010 |
Why?
|
| Complement C3 | 1 | 2005 | 48 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 33 | 0.010 |
Why?
|
| Haploidy | 1 | 2004 | 19 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 678 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1578 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 434 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 78 | 0.010 |
Why?
|
| Sperm Count | 1 | 2004 | 79 | 0.010 |
Why?
|
| Death | 1 | 2004 | 69 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 573 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 135 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2003 | 43 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 61 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 36 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 125 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 26 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 524 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24173 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 55 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2004 | 225 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 135 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 546 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 281 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 380 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 448 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 240 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 239 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 490 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 878 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 529 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6132 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 885 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3891 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12364 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6323 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 2996 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 26884 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 29554 | 0.000 |
Why?
|